Cem Onal

49PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)AcceleratorsInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Sep 13, 2026
Prognostic Value of MRI-Derived Apparent Diffusion Coefficient in Intermediate-Risk Prostate Cancer Treated With Definitive Radiotherapy.

|Mar 30, 2026
Impact of Intraprostatic Simultaneous Integrated Boost on Long-Term Outcomes in Unfavorable Intermediate-Risk Prostate Cancer Treated With Dose-Escalated Radiotherapy and Short-Term Androgen Deprivation Therapy.

Cem Onal, Aysenur Elmali, Birhan Demirhan

|Dec 16, 2025
Impact of Adjuvant Radiotherapy and Mitotane on Survival in Localized Adrenocortical Carcinoma: A Retrospective Cohort Study.

Aysenur Elmali, Ozan Cem Guler, Gokhan Ozyigit

|Nov 04, 2025
Does transurethral resection of prostate increase toxicity risk after simultaneous integrated boost radiotherapy? A matched cohort study with long-term follow-up.

Aysenur Elmali, Birhan Demirhan, Ozan Cem Guler

|Sep 23, 2025
Long term outcomes of prostate cancer patients aged 55 years or younger treated with definitive radiotherapy: Trod 09-005 study.

Caglayan Selenge Beduk Esen, Aysenur Elmali, Birhan Demirhan

|Mar 11, 2025
Propensity Score Matched Analysis of External Beam Radiotherapy With or Without Focal Boost to Intraprostatic Lesions in Prostate Cancer.

Cem Onal, Ozan Cem Guler, Gurcan Erbay

Pageof 9

Frequent Collaborators

11 joint publications

Aysenur Elmali

10 joint publications

Ozan Cem Guler

9 joint publications

Birhan Demirhan

4 joint publications

Sezin Yuce Sari